Comment on

• Steroid-free immunosuppression in kidney transplantation: an editorial review.

  Hricik DE. Hricik DE. Am J Transplant. 2002 Jan;2(1):19-24. doi: 10.1034/j.1600-6143.2002.020105.x. Am J Transplant. 2002. PMID: 12095051 Review. No abstract available.
• Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil.

  Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A. Vincenti F, et al. Am J Transplant. 2003 Mar;3(3):306-11. doi: 10.1034/j.1600-6143.2003.00005.x. Am J Transplant. 2003. PMID: 12614286 Clinical Trial.
• Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study.

  ter Meulen CG, van Riemsdijk I, Hené RJ, Christiaans MH, Borm GF, van Gelder T, Hilbrands LB, Weimar W, Hoitsma AJ. ter Meulen CG, et al. Am J Transplant. 2004 May;4(5):803-10. doi: 10.1111/j.1600-6143.2004.00419.x. Am J Transplant. 2004. PMID: 15084178 Clinical Trial.
• Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients.

  Opelz G, Döhler B, Laux G; Collaborative Transplant Study. Opelz G, et al. Am J Transplant. 2005 Apr;5(4 Pt 1):720-8. doi: 10.1111/j.1600-6143.2004.00765.x. Am J Transplant. 2005. PMID: 15760395